EcoDrugPlus

Calcium Channel, Voltage-Dependent, Beta 1 Subunit

Ensembl ID : ENSMSIG00000016291
Gene Symbol: CACNB1
1 Cross references
225 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 2 Subunit

Ensembl ID : ENSMSIG00000031316
Gene Symbol: CACNB2
1 Cross references
216 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 3 Subunit

Ensembl ID : ENSMSIG00000000901
Gene Symbol: CACNB3
1 Cross references
290 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 1

Ensembl ID : ENSMSIG00000023049
Gene Symbol: CACNG1
1 Cross references
279 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 2

Ensembl ID : ENSMSIG00000020664
Gene Symbol: CACNG2
1 Cross references
274 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 3

Ensembl ID : ENSMSIG00000028360
Gene Symbol: CACNG3
1 Cross references
271 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 5

Ensembl ID : ENSMSIG00000023007
Gene Symbol: CACNG5
1 Cross references
264 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 6

Ensembl ID : ENSMSIG00000006698
Gene Symbol: CACNG6
1 Cross references
263 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 7

Ensembl ID : ENSMSIG00000006664
Gene Symbol: CACNG7
1 Cross references
268 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 8

Ensembl ID : ENSMSIG00000006679
Gene Symbol: CACNG8
1 Cross references
253 Possible Orthologues:

Calcium-Sensing Receptor

Ensembl ID : ENSMSIG00000016850
Gene Symbol: CASR
1 Cross references
217 Possible Orthologues:

Cannabinoid Receptor 1 (Brain)

Ensembl ID : ENSMSIG00000011422
Gene Symbol: CNR1
1 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).